Gregory Curt, M.D. Chairman, Life Sciences Consortium of the CEO Roundtable on Cancer and US Medical Science Lead for Emerging Products, AstraZeneca Oncology
Step Change in Safe Harbors: Public–Private Partnerships
John E. Niederhuber, M.D., Director, National Cancer Institute
Facilitating Patient-Centered Cancer Research and a New Era of Drug Discovery
Mark B. McClellan, M.D., Ph.D., Director, Engleberg Center for Health Care Reform, Brookings Institution and Joshua S. Benner, PharmD, ScD, Research Director, Engleberg Center for Health Care Reform, Brookings Institution
Four Important Steps Toward 21st Century Care for Patients with Cancer
David R. Epstein, President and CEO, Novartis Oncology & Novartis Molecular Diagnostics
Vision and Will: The Future of the FDA